DTCA

AcronymDefinition
DTCADirect-To-Consumer Advertising
DTCADutch Tax and Customs Administration (Netherlands)
DTCADiabetes Treatment Centers of America (diabetes treatment network; various locations; now American Healthways)
DTCAD Trust Certifikacna Autorita (Slovak: D Trust Certification Authority)
DTCADwell-Time Code Acquisition
DTCADefect-Tolerant Computer Architecture
References in periodicals archive ?
DTCA of prescription pharmaceuticals is banned in most countries due to perceived deleterious effects on rational prescribing, pharmaceutical expenditure, and health outcomes.
Advertising also seems to have an influence on patients and or physicians, since new drugs with DTCA are nine times more likely to be prescribed than those new drugs without DTCA.
There is also an option for industry to submit promotional material for preapproval, before the first use, which may be the route taken for DTCA or new website material, for example.
The high potential for consumers to misattribute information across product categories as a result of DTCA and supplement advertising elevates the significance of new research in this area.
Advertising also seems to have an influence on patients and or physicians since new drugs with DTCA are nine times more likely to be prescribed those new drugs without DTCA.
17) Yet regulation of DTCA in the few countries where it is permitted has proven difficult largely due to legal protections afforded to forms of commercial free speech, such as in the USA, the world's largest pharmaceutical market.
In my experience, the goal of DTCA is to increase market share for the new drug by bringing awareness to a particular disease that the drug treats.
Although the DTCA prohibition remains hypothetical, the FDA did at
Physicians often accommodate requests for DTCA medications (SOR: C, 4 surveys).
In short, while DTCA is permitted in the United States, it is not permitted in Canada.
This study investigates the separate effects of broadcast and non-broadcast DTCA on price and demand, utilizing an extended time series of monthly records for all advertised and non-advertised drugs in four major therapeutic classes spanning 1994-2005, a period which enveloped the shifts in FDA guidelines and the large expansions in DTCA.
This has led to a great deal of debate in the medical profession and among health care insurer and managed care organizations and an ongoing review of advertising rules by the FDA However, very little is actually known about the effects of DTCA for the efficient allocation o prescription drugs.